Post-progression survival after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor for advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.

被引：0
|
作者：
Kogure, Yoshihito
Kitagawa, Chiyoe
Oki, Masahide
Saka, Hideo
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
[2] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19005
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis
    Zhang, Xiao-Hang
    Li, Cheng
    Dai, Chen-Fei
    Zhou, Bao-Sen
    THORACIC CANCER, 2011, 2 (03) : 101 - 108
  • [22] Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
    Kim, Woo-Jin
    Kim, Sunmin
    Choi, Hayoung
    Chang, Jinsun
    Shin, Hong-Joon
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Kyu-Sik
    Kim, Young-Chul
    Choi, Yoo-Duk
    THORACIC CANCER, 2015, 6 (06) : 800 - 804
  • [23] An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer
    Yoshimura, Akihiro
    Uchino, Junji
    Tanimura, Keiko
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Takeda, Takayuki
    Hiranuma, Osamu
    Hasegawa, Isao
    Kubota, Yutaka
    Shiotsu, Shinsuke
    Takumi, Chieko
    Hiraoka, Noriya
    Yamada, Tadaaki
    Takayama, Koichi
    MEDICINE, 2018, 97 (40)
  • [24] HOW SENSITIVE ARE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS FOR SQUAMOUS CELL CARCINOMA OF THE LUNG HARBORING EPIDERMAL GROWTH FACTOR RECEPTOR GENE SENSITIVE MUTATIONS?
    Hata, A.
    Katakami, N.
    Kunimasa, K.
    Yoshioka, H.
    Fujita, S.
    Kaji, R.
    Imai, Y.
    Tomii, K.
    Iwasaku, M.
    Nishiyama, A.
    Ishida, T.
    RESPIROLOGY, 2011, 16 : 185 - 185
  • [25] Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors
    Imai, Hisao
    Kaira, Kyoichi
    Mori, Keita
    Kotake, Mie
    Mitani, Masumi
    Kawashima, Naoko
    Hisada, Takeshi
    Minato, Koichi
    THORACIC CANCER, 2019, 10 (12) : 2200 - 2208
  • [26] Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Kujtan, Lara
    Subramanian, Janakiraman
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 547 - 559
  • [27] Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Lee, Jae Cheol
    Jang, Seung Hun
    Lee, Kye Young
    Kim, Young-Chul
    CANCER RESEARCH AND TREATMENT, 2013, 45 (02): : 79 - 85
  • [28] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Chung, Doo Hyun
    Heo, Dae Seog
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 594 - 600
  • [29] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
    Bhumsuk Keam
    Dong-Wan Kim
    Jin Hyun Park
    Jeong-Ok Lee
    Tae Min Kim
    Se-Hoon Lee
    Doo Hyun Chung
    Dae Seog Heo
    International Journal of Clinical Oncology, 2014, 19 : 594 - 600
  • [30] Subsequent treatment of epidermal growth factor receptor-tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma
    Qiao, Xiaojuan
    Zhang, Ye
    Wang, Jinghui
    Nong, Jingying
    Li, Xi
    Yang, Xinjie
    Lv, Jialin
    Zhang, Hui
    Qin, Na
    Zhang, Quan
    Yue, Wentao
    Zhang, Shucai
    THORACIC CANCER, 2015, 6 (06) : 678 - 686
12345